The effect of rifampin on the pharmacokinetics of vinorelbine in the micropig

Anticancer Research

Volumn 23, Issue 3 B, 2003, Pages 2741-2744

  Leveque, Dominique ^a,b   Wisniewski, Sandra ^a   Renault, Corinne ^b   Peter, Jean Daniel ^b   Le Corre, Pascal ^c   Monteil, Henri ^b   Jehl, François ^b  

^a HÔPITAL DE HAUTEPIERRE   (France)

^b Institut de Bacteriologie   (France)

^c Institute de Chimie de'Rennes   (France)

Author keywords

Interaction; Micropig; Pharmacokinetics; Rifampin; Vinorelbine

Indexed keywords

ALKALOID; CYTOCHROME P450 3A4; ITRACONAZOLE; NAVELBINE; NIFEDIPINE; RIFAMPICIN; VINBLASTINE; VINCRISTINE; VINDESINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ARTICLE; BIOTRANSFORMATION; BLOOD SAMPLING; CATHARANTHUS; CELL PROLIFERATION; CONTROLLED STUDY; DRUG EFFECT; DRUG ELIMINATION; DRUG HALF LIFE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; LIVER MICROSOME; LUNG NON SMALL CELL CANCER; NONHUMAN; PRIORITY JOURNAL; SWINE;

ANIMALS; ANTIBIOTICS, ANTITUBERCULAR; ANTINEOPLASTIC AGENTS, PHYTOGENIC; CYTOCHROME P-450 ENZYME SYSTEM; DRUG INTERACTIONS; ENZYME INDUCTION; FEMALE; RIFAMPIN; SWINE; SWINE, MINIATURE; VINBLASTINE;

EID: 0042807469     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Ngan VK, Bellman K, Panda D, Hill BT, Jordan MA and Wilson L: Novel actions of the antitumor drugs vinflunine and vinorelbine on microtubules. Cancer Res 60: 5045-5051, 2000.
2. Ngan VK, Bellman K, Hill BT, Wilson L and Jordan MA: Mechanism of mitotic block and inhibition of cell proliferation by the semisynthetic vinca alkaloids vinorelbine and its newer derivative vinflunine. Mol Pharmacol 60: 225-232, 2001.
3. Levêque D and Jehl F: Clinical pharmacokinetics of vinorelbine. Clin Pharmacokinet 31: 184-197, 1996.
4. Puozzo C, Zorza G, Gimbaud R, van Heugen JC, de Graeve J, Chatelut E, Variol P, Canal P, Fahy J and Bugat R: Metabolism of vinorelbine in human: clinical application. Proc Am Assoc Cancer Res 41: 280 (abstract), 2000.
5. Kajita J, Kuwabara T, Kobayashi H and Kobayashi S: CYP3A4 is mainly responsible for the metabolism of a new vinca alkaloid, vinorelbine, in human liver microsomes. Drug Metab Dispos 28: 1121-1127, 2000.
6. Panepinto LM and Phillips RW: The Yucatan miniature pig: characterization and utilization in biomedical research. Lab Anim Sci 36: 344-347, 1986.
7. Swindle MM and Smith AC: Comparative anatomy and physiology of the pig. Scand J Lab Anim Sci 23: 1-10, 1997.
8. Anzenbacher P, Soucek P, Anzenbacherova E, Gut I, Hruby K, Svoboda Z and Kvetina J: Presence and activity of cytochrome P450 isoforms in minipig liver microsomes. Drug Metab Dispos 26: 56-59, 1998.
9. Lu C and Li AP: Species comparison in P450 induction: effects of dexamethasone, omeprazole, and rifampin on P450 isoforms 1A and 3A in primary cultured hepatocytes from man, Sprague-Dawley rat, minipig, and beagle dog. Chem Biol Interact 134: 271-281, 2001.
10. Kaltenbach G, Levêque D, Peter JD, Salmon J, Elkhaïli H, Cavalier A, Salmon Y, Monteil H and Jehl F: Pharmacokinetic interaction between itraconazole and rifampin in Yucatan miniature pigs. Antimicrob Agents Chemother 40: 2043-2046, 1996.
11. Levêque D, Merle-Melet M, Bresler L, Didelot JP, Aymard JP, Wihlm J and Jehl F: Biliary elimination and pharmacokinetics of vinorelbine in micropigs. Cancer Chemother Pharmacol 32: 487-490, 1993.
12. Levêque D, Elkhaïli H, Peter JD, Linger L, Salmon J, Cavalier A, Salmon Y, Monteil H and Jehl F: Pharmacokinetics of vinorelbine in a chronic model of catheterized micropig. Pharm Res 13: S484 (abstract), 1996.
13. Panepinto LM, Phillips RW, Norden S, Pryor PC and Cox R: A comfortable, minimum stress method of restraint for Yucatan miniature swine. Lab Anim Sci 33: 95-97, 1983.
14. Jehl F, Debs J, Herlin C, Quoix E, Gallion C and Monteil H: Determination of navelbine and desacetyinavelbine in biological fluids by high performance liquid chromatography. J Chromatogr 525: 225-233, 1990.
15. Zhou-Pan XR, Sérée E, Zhou XJ, Placidi M, Maurel P, Barra Y and Rahmani R: Involvement of human liver cytochrome P450 3A in vinblastine metabolism: drug interactions. Cancer Res 53: 5121-5126, 1993.
16. Zhou XJ, Zhou-Pan XR, Gauthier T, Placidi M, Maurel P and Rahmani R: Human liver microsomal cytochrome P450 3A isozymes mediated vindesine biotransformation. Biochem Pharmacol 45: 853-861, 1993.
17. Chan JD: Pharmacokinetic drug interactions of vinca alkaloids: summary of case reports. Pharmacotherapy 18: 1304-1307, 1998.
18. Murphy JA, Ross LM and Gibson BES: Vincristine toxicity in five children with acute lymphoblastic leukemia. Lancet 346: 443, 1995.
19. Fedeli L, Colozza M, Boschetti E, Sabalich I, Aristei C, Guerciolini R, del Favero A, Rossetti R, Tonato M, Rambotti P and Davis S: Pharmacokinetics of vincristine in cancer patients treated with nifedipine. Cancer 64: 1805-1811, 1989.
20. Villikka K, Kivistö KT, Mäenpää H, Joensuu H and Neuvonen PJ: Cytochrome P450-inducing antiepileptics increase the clearance of vincristine in patients with brain tumors. Clin Pharmacol Ther 66: 589-593, 1999.